Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rockwell Medical (RMTI) Invested Capital (2016 - 2025)

Historic Invested Capital for Rockwell Medical (RMTI) over the last 17 years, with Q3 2025 value amounting to $37.9 million.

  • Rockwell Medical's Invested Capital rose 2303.7% to $37.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.9 million, marking a year-over-year increase of 2303.7%. This contributed to the annual value of $34.1 million for FY2024, which is 4592.58% up from last year.
  • Rockwell Medical's Invested Capital amounted to $37.9 million in Q3 2025, which was up 2303.7% from $31.6 million recorded in Q2 2025.
  • In the past 5 years, Rockwell Medical's Invested Capital registered a high of $37.9 million during Q3 2025, and its lowest value of -$1.8 million during Q1 2022.
  • In the last 5 years, Rockwell Medical's Invested Capital had a median value of $23.3 million in 2022 and averaged $23.0 million.
  • As far as peak fluctuations go, Rockwell Medical's Invested Capital crashed by 10666.01% in 2022, and later surged by 91919.3% in 2023.
  • Quarter analysis of 5 years shows Rockwell Medical's Invested Capital stood at $23.1 million in 2021, then increased by 0.74% to $23.3 million in 2022, then grew by 0.31% to $23.4 million in 2023, then skyrocketed by 45.93% to $34.1 million in 2024, then rose by 11.1% to $37.9 million in 2025.
  • Its Invested Capital was $37.9 million in Q3 2025, compared to $31.6 million in Q2 2025 and $32.9 million in Q1 2025.